Activating mutations in different components of the PI3K/Akt pathway occur in 49% of mCRPC, including mutations of PTEN (>40% of cases), and are solidly implicated in PCa progression (37, 38). This evidence concerns the gene AKT1 and posterior cortical atrophy.